Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance
Date of publication: 17-06-2017
There is a reasonable probability that the patient may experience adverse events, ranging from fever, chills and malaise, to severe adverse events including systemic invasive mycoses or systemic bacterial sepsis. Źródło: https://www.fda.gov
